BioCatalystWatch
MIRAWorkspace / MIRA / OverviewCompany library
MIRA PHARMACEUTICALS, INC. logo

MIRA PHARMACEUTICALS, INC.

MIRA PHARMACEUTICALS, INC. (MIRA)

Website

Price
Market cap
Next catalystPhase 2a CIPN initiation targeted for Q2 2027, subject to FDA clearance, site readiness, and other regulatory and operational factorsKetamir-2 — planned Phase 2a CIPN study · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Ketamir-2

NMDA receptor (PCP site)

PreINDP1P3FilingApproved
Upcoming / outlook

MIRA-55

CB1 receptor × CB2 receptor

Upcoming / outlook

SKNY-1

CB1 receptor × CB2 receptor × MAO-B

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

MIRA-55

CB1 receptor × CB2 receptor

Upcoming / outlook

SKNY-1

CB1 receptor × CB2 receptor × MAO-B

Upcoming / outlook

Ketamir-2

NMDA receptor (PCP site)

PreINDP1P3FilingApproved
Upcoming / outlook

Other pipelines

Ketamir-2

NMDA receptor (PCP site)

Ketamir-2

NMDA receptor (PCP site)

PreINDP1P2P3FilingApproved
MIRA-55

CB1 receptor × CB2 receptor

MIRA-55

CB1 receptor × CB2 receptor

History / paused

Ketamir-2

NMDA receptor (PCP site)

PreINDP1P2P3FilingApproved

CB1 receptor × CB2 receptor

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MIRA PR & News

PR & News

MIRA SEC archive